CompChem-Database: compound details

CompChem-Database: details for selected entry

DB00637_p0 (701)

Formula C₂₈H₃₁FN₄O

MW 458.58

InChIKey GXDALQBWZGODGZ-SREBMQDQNA-N

Entry_Date 2023-09-01

Net_Charge 0

Number_Atoms 65

Number_Heavy_Atoms 34

Number_Rings 5

Number_Bonds 69

Rotat_Bonds 8

Unbranched_Chain 2

Chiral_Centers 0

ONatoms 5

HB_Donor 1

HB_Acceptor 1

OpenEye_HB_Donors 1

OpenEye_HB_Acceptors 2

Lipinski_HB_Donors 1

Lipinski_HB_Acceptors 5

Lipinski_Violations 1

XLogP3 0

XLogP 5.66

logP 5.3622

PSA 42.32

MR 139.264

ABS 0.55

Solubility poorly

Aggregator Pass

PM7_Heat_of_Formation_kcal_per_mol 17.69516

PM7_Total_Energy_ev -5361.76492

PM7_Electronic_Energy_ev -50541.94145

PM7_Dipole_Debye 4.86766

PM7_Point_Group C1

PM7_HOMO_Energy_ev -8.213

PM7_LUMO_Energy_ev -0.525

PM7_COSMO_Area_square_ang 452.28

PM7_COSMO_Volue_cubic_ang 569.91

PM7_Electron_Affinity_ev 0.525

PM7_Ionization_Energy_ev 8.213

PM7_Energy_Gap_ev 7.688

PM7_Global_Hardness_ev 3.844

PM7_Global_Softness_ev 0.2601456815816857

PM7_Chemical_Potential_ev -4.369

PM7_Electronigativity_ev 4.369

PM7_Back_Donation_Energy_ev -0.961

PM7_Electrophilicity_ev 2.482851326742976

OPENEYE_Name 1-[(4-fluorophenyl)methyl]-~{N}-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidyl]benzimidazol-2-amine

SMILES c1ccc2c(c1)nc(n2Cc3ccc(cc3)F)NC4CCN(CC4)CCc5ccc(cc5)OC

Canonical_SMILES COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2

InChI 1/C28H31FN4O/c1-34-25-12-8-21(9-13-25)14-17-32-18-15-24(16-19-32)30-28-31-26-4-2-3-5-27(26)33(28)20-22-6-10-23(29)11-7-22/h2-13,24H,14-20H2,1H3,(H,30,31)/f/h30H

InChI_3D 1S/C28H31FN4O/c1-34-25-12-8-21(9-13-25)14-17-32-18-15-24(16-19-32)30-28-31-26-4-2-3-5-27(26)33(28)20-22-6-10-23(29)11-7-22/h2-13,24H,14-20H2,1H3,(H,30,31)

AuxInfo 1/1/N:25,1,2,7,8,5,6,3,4,11,12,9,10,26,20,21,28,22,23,27,13,14,18,24,17,15,16,19,34,32,29,31,30,33/E:(6,7)(8,9)(10,11)(12,13)(15,16)(18,19)/F:m/E:m/rA:65nCCCCCCCCCCCCCCCCCCCCCCCCCCCCNNNNOFHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:d1;;;;;s1;s2;d3;s4;d5;s6;s3d4;s5d6;d7;d8s15;s9d10;s11d12;;;;s20;s21;s20s21;;s13;s14;s26;s15d19;s16s19s27;s22s23s28;s19s24;s17s25;s18;s1;s2;s3;s4;s5;s6;s7;s8;s9;s10;s11;s12;s20;s20;s21;s21;s22;s22;s23;s23;s24;s25;s25;s25;s26;s26;s27;s27;s28;s28;s32;/rC:;0,1.0058,0;4.6895,-5.9387,0;2.9805,-5.6392,0;2.6406,3.9601,0;4.2907,3.4239,0;.868,-.4979,0;.868,1.5137,0;4.5159,-6.9288,0;2.807,-6.6293,0;2.9513,4.9161,0;4.6013,4.3799,0;3.9209,-5.2989,0;3.3119,3.2189,0;1.736,-.0013,0;1.736,1.0058,0;3.5738,-7.2791,0;3.9332,5.1309,0;3.2858,.5022,0;5.5544,-1.0035,0;3.8455,-.704,0;5.3809,-1.9936,0;3.672,-1.6941,0;4.7858,-.3637,0;4.1679,-8.9061,0;4.0935,-4.3139,0;3.0029,2.2678,0;4.2661,-3.3289,0;2.6938,-.3126,0;2.6938,1.3168,0;4.4388,-2.344,0;4.2858,.5023,0;3.4012,-8.2641,0;4.2423,6.0819,0;-.4327,-.2506,0;-.4337,1.2545,0;5.1589,-5.7665,0;2.5976,-5.3176,0;2.1517,3.8555,0;4.6247,3.0519,0;.8677,-.9979,0;.868,2.0137,0;4.9002,-7.2487,0;2.3368,-6.7994,0;2.6156,5.2867,0;5.0907,4.4824,0;5.8032,-.5698,0;6.0246,-1.1736,0;3.3455,-.704,0;3.7591,-.2115,0;5.8809,-1.9921,0;5.4702,-2.4856,0;3.4207,-2.1264,0;3.2023,-1.5227,0;5.1682,-.0416,0;4.4889,-8.5228,0;3.8469,-9.2895,0;4.5512,-9.2271,0;3.601,-4.2276,0;4.586,-4.4002,0;3.4784,2.1133,0;2.5273,2.4224,0;3.7736,-3.2426,0;4.7586,-3.4153,0;4.5358,.9353,0;

Duplicates DB00637_p0

mol2_Path /CCDB/DrugBank/Database/Compound-0000000000-0000049999/Compound-0000000500-0000000749/DB00637_p0.mol2

pdbqt_Path /CCDB/DrugBank/Database/Compound-0000000000-0000049999/Compound-0000000500-0000000749/DB00637_p0.pdbqt

sdf_Path /CCDB/DrugBank/Database/Compound-0000000000-0000049999/Compound-0000000500-0000000749/DB00637_p0.sdf

Formula	C₂₈H₃₁FN₄O
MW	458.58
InChIKey	GXDALQBWZGODGZ-SREBMQDQNA-N
Entry_Date	2023-09-01
Net_Charge	0
Number_Atoms	65
Number_Heavy_Atoms	34
Number_Rings	5
Number_Bonds	69
Rotat_Bonds	8
Unbranched_Chain	2
Chiral_Centers	0
ONatoms	5
HB_Donor	1
HB_Acceptor	1
OpenEye_HB_Donors	1
OpenEye_HB_Acceptors	2
Lipinski_HB_Donors	1
Lipinski_HB_Acceptors	5
Lipinski_Violations	1
XLogP3	0
XLogP	5.66
logP	5.3622
PSA	42.32
MR	139.264
ABS	0.55
Solubility	poorly
Aggregator	Pass
PM7_Heat_of_Formation_kcal_per_mol	17.69516
PM7_Total_Energy_ev	-5361.76492
PM7_Electronic_Energy_ev	-50541.94145
PM7_Dipole_Debye	4.86766
PM7_Point_Group	C1
PM7_HOMO_Energy_ev	-8.213
PM7_LUMO_Energy_ev	-0.525
PM7_COSMO_Area_square_ang	452.28
PM7_COSMO_Volue_cubic_ang	569.91
PM7_Electron_Affinity_ev	0.525
PM7_Ionization_Energy_ev	8.213
PM7_Energy_Gap_ev	7.688
PM7_Global_Hardness_ev	3.844
PM7_Global_Softness_ev	0.2601456815816857
PM7_Chemical_Potential_ev	-4.369
PM7_Electronigativity_ev	4.369
PM7_Back_Donation_Energy_ev	-0.961
PM7_Electrophilicity_ev	2.482851326742976
OPENEYE_Name	1-[(4-fluorophenyl)methyl]-~{N}-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidyl]benzimidazol-2-amine
SMILES	c1ccc2c(c1)nc(n2Cc3ccc(cc3)F)NC4CCN(CC4)CCc5ccc(cc5)OC
Canonical_SMILES	COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2
InChI	1/C28H31FN4O/c1-34-25-12-8-21(9-13-25)14-17-32-18-15-24(16-19-32)30-28-31-26-4-2-3-5-27(26)33(28)20-22-6-10-23(29)11-7-22/h2-13,24H,14-20H2,1H3,(H,30,31)/f/h30H
InChI_3D	1S/C28H31FN4O/c1-34-25-12-8-21(9-13-25)14-17-32-18-15-24(16-19-32)30-28-31-26-4-2-3-5-27(26)33(28)20-22-6-10-23(29)11-7-22/h2-13,24H,14-20H2,1H3,(H,30,31)
AuxInfo	1/1/N:25,1,2,7,8,5,6,3,4,11,12,9,10,26,20,21,28,22,23,27,13,14,18,24,17,15,16,19,34,32,29,31,30,33/E:(6,7)(8,9)(10,11)(12,13)(15,16)(18,19)/F:m/E:m/rA:65nCCCCCCCCCCCCCCCCCCCCCCCCCCCCNNNNOFHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:d1;;;;;s1;s2;d3;s4;d5;s6;s3d4;s5d6;d7;d8s15;s9d10;s11d12;;;;s20;s21;s20s21;;s13;s14;s26;s15d19;s16s19s27;s22s23s28;s19s24;s17s25;s18;s1;s2;s3;s4;s5;s6;s7;s8;s9;s10;s11;s12;s20;s20;s21;s21;s22;s22;s23;s23;s24;s25;s25;s25;s26;s26;s27;s27;s28;s28;s32;/rC:;0,1.0058,0;4.6895,-5.9387,0;2.9805,-5.6392,0;2.6406,3.9601,0;4.2907,3.4239,0;.868,-.4979,0;.868,1.5137,0;4.5159,-6.9288,0;2.807,-6.6293,0;2.9513,4.9161,0;4.6013,4.3799,0;3.9209,-5.2989,0;3.3119,3.2189,0;1.736,-.0013,0;1.736,1.0058,0;3.5738,-7.2791,0;3.9332,5.1309,0;3.2858,.5022,0;5.5544,-1.0035,0;3.8455,-.704,0;5.3809,-1.9936,0;3.672,-1.6941,0;4.7858,-.3637,0;4.1679,-8.9061,0;4.0935,-4.3139,0;3.0029,2.2678,0;4.2661,-3.3289,0;2.6938,-.3126,0;2.6938,1.3168,0;4.4388,-2.344,0;4.2858,.5023,0;3.4012,-8.2641,0;4.2423,6.0819,0;-.4327,-.2506,0;-.4337,1.2545,0;5.1589,-5.7665,0;2.5976,-5.3176,0;2.1517,3.8555,0;4.6247,3.0519,0;.8677,-.9979,0;.868,2.0137,0;4.9002,-7.2487,0;2.3368,-6.7994,0;2.6156,5.2867,0;5.0907,4.4824,0;5.8032,-.5698,0;6.0246,-1.1736,0;3.3455,-.704,0;3.7591,-.2115,0;5.8809,-1.9921,0;5.4702,-2.4856,0;3.4207,-2.1264,0;3.2023,-1.5227,0;5.1682,-.0416,0;4.4889,-8.5228,0;3.8469,-9.2895,0;4.5512,-9.2271,0;3.601,-4.2276,0;4.586,-4.4002,0;3.4784,2.1133,0;2.5273,2.4224,0;3.7736,-3.2426,0;4.7586,-3.4153,0;4.5358,.9353,0;
Duplicates	DB00637_p0
mol2_Path	/CCDB/DrugBank/Database/Compound-0000000000-0000049999/Compound-0000000500-0000000749/DB00637_p0.mol2
pdbqt_Path	/CCDB/DrugBank/Database/Compound-0000000000-0000049999/Compound-0000000500-0000000749/DB00637_p0.pdbqt
sdf_Path	/CCDB/DrugBank/Database/Compound-0000000000-0000049999/Compound-0000000500-0000000749/DB00637_p0.sdf